French prosecutors have launched a probe over allegations of “planned obsolescence” in Apple’s iPhone.
Under French law it is a crime to intentionally shorten lifespan of a product with the aim of making customers replace it.
In December, Apple admitted that older iPhone models were deliberately slowed down through software updates.
But it insisted it was because the phones’ battery performance diminished over time.
The French investigation is being led by the economy ministry’s consumer protection agency. It follows a legal complaint filed in December by pro-consumer group Stop Planned Obsolescence (Hop).
Hop said France was the third country to investigate Apple after Israel and the US, but the only one in which the alleged offense was a crime. Penalties could include up to 5% of annual turnover or even a jail term.
The group alleged that Apple had both deliberately slowed down some iPhone models through a software update and timed the update to coincide with the release of the newer model, the iPhone 8.
“The slowing down of older devices seems to have the deliberate aim of pushing Apple customers towards purchasing the new model,” the group said.
Full Content: The Guardian
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Sex Toy Retailer Says Google Breaches EU Digital Market Rules
May 20, 2025 by
CPI
Latham & Watkins Expands Brussels Antitrust Team
May 20, 2025 by
CPI
Brazil’s Antitrust Watchdog Expected to Approve Pet Retail Merger Without Conditions
May 20, 2025 by
CPI
EU and UK Finalize Deal to Strengthen Antitrust Cooperation
May 20, 2025 by
CPI
Clemens Food Group Reaches $13.5 Million Settlement in Pork Price-Fixing Suit
May 20, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas